Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
about
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer PhenotypesPreeclampsia, hypoxia, thrombosis, and inflammationPlasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.Role of tissue factor in venous thrombosis.Tissue factor, blood coagulation, and beyond: an overview.High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor ExtensionSynchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis.Effect of ovarian tumor characteristics on venous thromboembolic risk.High incidence of silent venous thromboembolism before treatment in ovarian cancer.Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States.Venous thrombosis and cancer: from mouse models to clinical trials.A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted TherapiesIncidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.Silent venous thromboembolism before treatment in endometrial cancer and the risk factorsTissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.Tissue factor, angiogenesis and tumour progression.New insights into cancer-associated thrombosis.Role of tissue factor in cancer.Assessing risk of venous thromboembolism in the patient with cancer.Predictive value of microparticle-associated tissue factor activity for permeability glycoprotein-mediated multidrug resistance in cancer.Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.Thrombosis in ovarian cancer: a case control study.Risk assessment models for cancer-associated venous thromboembolism.The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism.Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer.Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.Thrombosis and cancerCancer-associated thrombosis: The search for the holy grail continues
P2860
Q26781924-BF0A5A5F-7670-463D-882E-717CC414A00AQ27000388-D03ACB31-2413-4B4F-A83E-8F4F0F1FE2FCQ33765406-9AF558EC-FD3A-4C30-90F0-9FDE50413EFCQ34795476-7C181AEC-943C-4096-B651-3B8B4E5956ABQ35222618-9D67E7A8-7A4C-462E-A2F3-ED464FD04DF9Q35529221-C3303C6E-ACE1-4A7A-9D97-DC3522347D30Q36226124-721B7486-97FC-4135-A711-17450DF31F75Q36547036-E94243CD-6FE2-4048-B6C6-1902530CC673Q36611427-4E69D208-ACFF-418C-BB3C-9DC6ED02D8B1Q36617694-8A983E83-2CF7-4BE0-8692-A6D22F797FA2Q36636558-78283D3F-B540-47FC-A33C-F1454B9798CAQ36790208-D7B3D415-B630-4561-8982-7EFD65354C2AQ36812718-56B90A99-92C3-4170-9071-0BA7E3D5A4AEQ36936002-F67AEA1E-89AA-4172-BFBC-32E5F527594BQ36972097-FC6593B7-7EBA-4F82-B661-184288D06857Q37122001-0D3B0370-80B3-4763-9478-CCFDA3BA66FCQ37307380-04DF4284-E1FA-4CA7-B22C-49F682550412Q37393391-5F2C1966-555B-4EE4-856E-60430D5C2535Q37393394-B64AE048-C14E-401C-9670-BA751E3A0AFDQ37406897-BB7ADF20-7DD9-4826-99D8-A6DDEDC1C8F8Q37481868-EBC6BCB9-FF9C-4D72-813F-5919C288EB25Q37631412-228933AD-D545-454F-B312-32B792C45709Q37632172-BE94FCB5-AFA8-4016-BFDB-F1EBEAEC9B6BQ37956590-D215F259-A7A6-45AD-A2F9-C227E7670EB4Q38747529-A480EAD6-2CA8-4BBF-BAF2-F5B3868D9486Q39762177-EB12E88E-10B7-4EFD-B8A8-F1342EE031E1Q40824665-4C2C97BD-0D9F-4924-8D29-B0B86AB139B3Q42277708-CBB1FAFB-6E57-406F-9E63-DA1DC696A276Q47192469-AD710076-DF5B-4A70-A4D8-8FF5A45BF660Q56339353-E06E085F-6E66-4A8D-B4B9-A38901E7C198Q57824763-0E59C1B1-E8DC-4388-9D58-A6AF5BCBF955
P2860
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
@en
type
label
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
@en
prefLabel
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
@en
P2093
P2860
P356
P1476
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
@en
P2093
H Yoshikawa
I Yamaguchi
K Matsumoto
K Nakanishi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603552
P407
P577
2007-01-09T00:00:00Z